501, 2022
NEW OPERATING THEATRES TO TACKLE WAITING LISTS
Two new operating theatres are to be built at Prince [...]
2012, 2021
Wales Community Pharmacy Contractual Framework agreement
An agreement has been reached on wide reaching reform of [...]
712, 2021
Record investment and training opportunities as NHS Wales grows
A massive £260 million investment will boost training and help [...]
-
Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM) GalleryLupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)
411, 2021
Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)
Slough, UK, 4 November 2021: Global pharma major Lupin today announces [...]
